{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "8757185", "DateCompleted": {"Year": "1996", "Month": "09", "Day": "16"}, "DateRevised": {"Year": "2021", "Month": "12", "Day": "03"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0027-8874", "JournalIssue": {"Volume": "88", "Issue": "16", "PubDate": {"Year": "1996", "Month": "Aug", "Day": "21"}}, "Title": "Journal of the National Cancer Institute", "ISOAbbreviation": "J Natl Cancer Inst"}, "ArticleTitle": "Raloxifene, retinoids, and lavender: \"me too\" tamoxifen alternatives under study.", "Pagination": {"StartPage": "1100", "EndPage": "1102", "MedlinePgn": "1100-2"}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [], "LastName": "Ziegler", "ForeName": "J", "Initials": "J"}], "PublicationTypeList": ["News"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Natl Cancer Inst", "NlmUniqueID": "7503089", "ISSNLinking": "0027-8874"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Hormonal"}, {"RegistryNumber": "0", "NameOfSubstance": "Drugs, Investigational"}, {"RegistryNumber": "0", "NameOfSubstance": "Estrogen Antagonists"}, {"RegistryNumber": "0", "NameOfSubstance": "Oils, Volatile"}, {"RegistryNumber": "0", "NameOfSubstance": "Piperidines"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Oils"}, {"RegistryNumber": "0", "NameOfSubstance": "Retinoids"}, {"RegistryNumber": "094ZI81Y45", "NameOfSubstance": "Tamoxifen"}, {"RegistryNumber": "0M67U6Z98F", "NameOfSubstance": "droloxifene"}, {"RegistryNumber": "456UXE9867", "NameOfSubstance": "idoxifene"}, {"RegistryNumber": "4F86W47BR6", "NameOfSubstance": "Raloxifene Hydrochloride"}, {"RegistryNumber": "7NFE54O27T", "NameOfSubstance": "Toremifene"}, {"RegistryNumber": "ZBP1YXW0H8", "NameOfSubstance": "lavender oil"}], "MeshHeadingList": [{"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Antineoplastic Agents, Hormonal"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Breast Neoplasms"}, {"QualifierName": [], "DescriptorName": "Clinical Trials as Topic"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Drugs, Investigational"}, {"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Estrogen Antagonists"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Lavandula"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neoplasms"}, {"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Oils, Volatile"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Ovarian Neoplasms"}, {"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Piperidines"}, {"QualifierName": [], "DescriptorName": "Plant Oils"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Prostatic Neoplasms"}, {"QualifierName": [], "DescriptorName": "Raloxifene Hydrochloride"}, {"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Retinoids"}, {"QualifierName": ["analogs & derivatives", "therapeutic use"], "DescriptorName": "Tamoxifen"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Toremifene"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1996", "Month": "8", "Day": "21"}, {"Year": "1996", "Month": "8", "Day": "21", "Hour": "0", "Minute": "1"}, {"Year": "1996", "Month": "8", "Day": "21", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["8757185", "10.1093/jnci/88.16.1100"]}}]}